Dr Reddy’s Lab to expand capacity of three manufacturing plants located in Telangana

06 Feb 2015 Evaluate

Dr Reddy’s Laboratories is planning to invest Rs 82 crore to expand the capacity of three of its bulk drugs and intermediates manufacturing plants located in Telangana. In this regard, the company has approached the Ministry of Environment and Forests for necessary approvals for expanding the combined capacity of three facilities to over 142 tonnes per month from existing 41 tonnes.

Dr Reddy's Laboratories, Chemical Techops-II has proposed for expansion of bulk drugs and intermediates manufacturing unit (from 21.9 TPM to 68.76 TPM) in Telangana’s Medak district.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×